Certain mutations and risk variants of the gene leucine-rich repeat kinase 2 (LRRK2; PARK8) are very common in the PD-afflicted population, accounting for approximately 5–15% of familial and sporadic PD [2]. The gene discussed is LRRK2; the disease is Parkinson disease.